Symbiotix Biotherapies Overview
- Year Founded
-
2009
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Symbiotix Biotherapies General Information
Description
Developer of a novel class of molecular therapeutics intended to treat inflammatory bowel disease. The company's novel class of molecular therapeutics are oral agents based on molecules derived from the human microbiom which are used for multiple sclerosis and other serious immune-mediated diseases, enabling patients to improve their lives and treat inflammatory disaeses.
Contact Information
Website
www.symbiotix-bio.comCorporate Office
- One International Place
- Suite 1400
- Boston, MA 02110
- United States
Corporate Office
- One International Place
- Suite 1400
- Boston, MA 02110
- United States
Symbiotix Biotherapies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Out of Business | 01-Oct-2019 | Completed | Out of Business | |||
| 5. Later Stage VC (Series A) | 01-Nov-2017 | Completed | Generating Revenue | |||
| 4. Grant | 21-Sep-2016 | Completed | Startup | |||
| 3. Later Stage VC | Completed | Startup | ||||
| 2. Grant | 01-Jun-2015 | $2.98M | Completed | Startup | ||
| 1. Grant | 15-Jul-2014 | $720K | Completed | Startup |
Symbiotix Biotherapies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A3 | ||||||||
| Series A2 | ||||||||
| Series A1 | 303,796 | $0.001000 | $7.9 | $7.9 | 1x | $7.9 | 10.88% |
Symbiotix Biotherapies Patents
Symbiotix Biotherapies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2013019896-A1 | Platform for identifying and/or characterizing immunomodulatory agents | Inactive | 01-Aug-2011 |
Symbiotix Biotherapies FAQs
-
When was Symbiotix Biotherapies founded?
Symbiotix Biotherapies was founded in 2009.
-
Where is Symbiotix Biotherapies headquartered?
Symbiotix Biotherapies is headquartered in Boston, MA.
-
What industry is Symbiotix Biotherapies in?
Symbiotix Biotherapies’s primary industry is Drug Discovery.
-
Is Symbiotix Biotherapies a private or public company?
Symbiotix Biotherapies is a Private company.
-
What is Symbiotix Biotherapies’s current revenue?
The current revenue for Symbiotix Biotherapies is .
-
How much funding has Symbiotix Biotherapies raised over time?
Symbiotix Biotherapies has raised $5M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process